Epidemiology & Forecasting

 

 

Decision Resources offers the industry’s leading epidemiology and market forecasts for the world’s most significant diseases.

Epidemiology
Decision Resources’ syndicated and custom epidemiology analyses quantify the relative burden of disease in major pharmaceutical and emerging markets. Our estimates provide the starting point for experienced analysts to model their own markets. The country-specific data we include in our analyses are recognized as the premier epidemiology in the industry.

Our epidemiology information includes:

• Prevalent and/or incident populations
• Diagnosed percentage and population 
• Drug-treated percentage and population 
• Country 
• Gender 
• Age 
• Comorbidity 
• Relevant disease subpopulations, including severity, lab measure, discharge diagnosis, time to presentation, seasonality and subtype 
• Forecasts of prevalent or incident populations based on expected changes in demographics and risk factors

The following product lines include our comprehensive epidemiological analyses:

• PatientBase
• Pharmacor
• Emerging Markets
• DecisionBase
• PatientFinder

Custom epidemiological analyses
Our epidemiology group integrates their expertise and proven epidemiological methods with our consulting group’s knowledge and skill to provide your company with a custom analysis that is tailored to your business needs.  Our epidemiology team can provide custom analyses for the world’s commonly occurring diseases as well as for rare, orphan, or difficult-to-study diseases.  We have experience working on custom analyses in the major pharmaceutical as well as emerging markets.

Market Forecasts
The backbone of our Pharmacor reports, market forecasts drive the decision-making of our pharmaceutical, biotechnology and financial clients. Our reports predict the success or failure of current and emerging drugs.

The following product lines include information to assist with planning a market forecast:

• DecisionBase
• Pharmacor